Innovation and Evolution in Psoriasis Management: Exploring Oral Therapy

Hear from Joseph Gorelick, MSN, FNP-C, Brad Glick, DO, MPH, Kara Gooding, MS, PA-C, and Linda Stein Gold, MD about the evolution in psoriasis treatments, including a new oral peptide that targets IL-23. They review data for safety and efficacy and address patient needs and preferences. Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.